Topical Collection on Antiphospholipid Syndrome
In this topical collection (47 articles)
-
Antiphospholipid Syndrome (D Erkan, Section Editor)
The Role of the Gut Microbiota in the Pathogenesis of Antiphospholipid Syndrome
William E. Ruff, Silvio M. Vieira, Martin A. Kriegel Article:472 -
ANTIPHOSPHOLIPID SYNDROME (D ERKAN, SECTION EDITOR)
Clinical Relevance of β2-Glycoprotein-I Plasma Levels in Antiphospholipid Syndrome (APS)
Alessandra Banzato, Vittorio Pengo Article:424 -
ANTIPHOSPHOLIPID SYNDROME (D ERKAN, SECTION EDITOR)
New Tests to Detect Antiphospholipid Antibodies: Antiprothrombin (aPT) and Anti-Phosphatidylserine/Prothrombin (aPS/PT) Antibodies
Savino Sciascia, Munther A. Khamashta… Article:415 -
ANTIPHOSPHOLIPID SYNDROME (D ERKAN, SECTION EDITOR)
Management of Recurrent Thrombosis in Antiphospholipid Syndrome
Cecilia Nalli, Laura Andreoli, Cinzia Casu, Angela Tincani Article:405 -
ANTIPHOSPHOLIPID SYNDROME (D ERKAN, SECTION EDITOR)
Pregnancy Morbidity in Antiphospholipid Syndrome: What Is the Impact of Treatment?
Guilherme R. de Jesús, Gustavo Rodrigues… Article:403 -
ANTIPHOSPHOLIPID SYNDROME (D ERKAN, SECTION EDITOR)
New Tests to Detect Antiphospholipid Antibodies: Anti-Domain I Beta-2-Glycoprotein-I Antibodies
Cecilia Beatrice Chighizola, Maria Gerosa… Article:402 -
ANTIPHOSPHOLIPID SYNDROME (D ERKAN, SECTION EDITOR)
Renal Involvement in Antiphospholipid Syndrome
Guillermo J. Pons-Estel, Ricard Cervera Article:397 -
ANTIPHOSPHOLIPID SYNDROME (RAS ROUBEY, SECTION EDITOR)
Clinical Significance of IgA Anti-Cardiolipin and IgA Anti-β2Glycoprotein I Antibodies
Laura Andreoli, Micaela Fredi, Cecilia Nalli… Article:343 -
ANTIPHOSPHOLIPID SYNDROME (RAS ROUBEY, SECTION EDITOR)
Use of New Oral Anticoagulants in Antiphospholipid Syndrome
Deepa Jayakody Arachchillage, Hannah Cohen Article:331 -
ANTIPHOSPHOLIPID SYNDROME (RAS ROUBEY, SECTION EDITOR)
Inhibition of Nitric Oxide and Antiphospholipid Antibody-Mediated Thrombosis
Chieko Mineo Article:324 -
ANTIPHOSPHOLIPID SYNDROME (RAS ROUBEY, SECTION EDITOR)
Valvular Heart Disease in Antiphospholipid Syndrome
Stéphane Zuily, Olivier Huttin, Shirine Mohamed… Article:320 -
ANTIPHOSPHOLIPID SYNDROME (RAS ROUBEY, SECTION EDITOR)
Duration of Anticoagulation Treatment for Thrombosis in APS: Is It Ever Safe to Stop?
Sinthiya Punnialingam, Munther A. Khamashta Article:318 -
Antiphospholipid Syndrome (S Zuily, Section Editor)
Epidemiology of Antiphospholipid Syndrome in the General Population
Jesse Y. Dabit, Maria O. Valenzuela-Almada… Article:85 -
Antiphospholipid Syndrome (S Zuily, Section Editor)
Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature
Virginie Dufrost, Jessie Risse, Stéphane Zuily, Denis Wahl Article:74 -
Antiphospholipid Syndrome (S Zuily, Section Editor)
The Role of Antiphospholipid Antibodies in COVID-19
Maximilian Stelzer, Jörg Henes, Sebastian Saur Article:72 -
Antiphospholipid Syndrome (S Zuily, Section Editor)
NETs in APS: Current Knowledge and Future Perspectives
Ajay Tambralli, Kelsey Gockman, Jason S. Knight Article:67 -
Antiphospholipid Syndrome (S Zuily, Section Editor)
Primary Thrombosis Prophylaxis in Persistently Antiphospholipid Antibody-Positive Individuals: Where Do We Stand in 2018?
Yu Zuo, Medha Barbhaiya, Doruk Erkan Article:66 -
Antiphospholipid Syndrome (S Zuily, Section Editor)
Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?
Thomas Foret, Virginie Dufrost, Lucie Salomon Du Mont… Article:65 -
Antiphospholipid Syndrome (S Zuily, Section Editor)
Genetics of Antiphospholipid Syndrome
Lourdes Ortiz-Fernández, Amr H Sawalha Article:65 -
Antiphospholipid Syndrome (S Zuily, Section Editor)
Vascular Manifestations in Antiphospholipid Syndrome (APS): Is APS a Thrombophilia or a Vasculopathy?
Salma Siddique, Jessie Risse, Guillaume Canaud… Article:64
Continue reading...
To view the rest of this content please follow the download PDF link above.